Class IIReported 2025-08-13

Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.

Recalled by AEQUITA PHARMACY

Reason for Recall

Lack of Processing Controls.

Recall Number

D-0554-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-07-18

Reported

2025-08-13

Distribution

MA

Code Info

All Lots within expiry

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.